Error: Could not add to watchlist. X

Rydex Series - Biotechnology Fund

+ Watchlist
RYOAX:US
NASDAQ GM
86.83
USD
1.03
1.20%
As of 18:05:00 ET on 08/28/2015.
Fund Type
Open-End Fund
52Wk Range
62.97 - 98.88
1 Yr Return
25.99%
YTD Return
15.71%
Open
86.83
Day Range
86.83 - 86.83
Previous Close
85.80
52Wk Range
62.97 - 98.88
1 Yr Return
25.99%
YTD Return
15.71%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
U.S.
NAV (on 08/27/2015)
85.8
Total Assets (m USD) (on 08/27/2015)
766.712
Inception Date
04/01/1998
Last Dividend (on 11/18/2014)
2.5745
Dividend Indicated Gross Yield
-
Fund Managers
MICHAEL PAUL BYRUM / RYAN A HARDER
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
-
12b-1 Fee
0.25%
Current Mgmt Fee
0.85%
Expense Ratio
1.83%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 534.84 k 63.04 m 7.14
Amgen Inc 318.74 k 56.29 m 6.38
Celgene Corp 382.89 k 50.25 m 5.69
Regeneron Pharmaceuticals Inc 67.71 k 37.49 m 4.25
Biogen Inc 112.80 k 35.96 m 4.07
Alexion Pharmaceuticals Inc 147.93 k 29.21 m 3.31
Vertex Pharmaceuticals Inc 202.47 k 27.33 m 3.10
Illumina Inc 114.22 k 25.05 m 2.84
BioMarin Pharmaceutical Inc 164.04 k 23.99 m 2.72
Incyte Corp 189.60 k 19.77 m 2.24
Profile
Rydex Series - Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests its assets in companies that are involved in the biotechnology industry, including companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products.
ADDRESS
Rydex Funds
9601 Blackwell Road
Suite 500
Rockville, MD 20850
USA
PHONE
1-301-296-5100